National Heart, Lung, and Blood Institute at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
National Heart, Lung, and Blood Institute brings 3 presentations to ASH 2026 in New Orleans. Its program spans immune-driven bone marrow failure, research funding for early-career faculty and new endpoints for sickle cell disease trials. It also covers how cells carrying acquired mutations gain ground in immune-mediated marrow failure.
| Organization | ASH 2026 Attendance |
|---|---|
National Heart, Lung, and Blood Institute Bethesda, MD | |
NIH institute that funds and conducts research on heart, lung, blood and sleep disorders, including sickle cell disease. | Talk Clonal Selection of Somatic Mutations in Immune Mediated BMF How acquired mutations are selected in immune and inherited bone marrow failure, and how genomic tests can track clones that progress to myeloid cancer. |
Instantly find 20 buyers from National Heart, Lung, and Blood Institute
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction